Value of Point of Care Troponin Testing in Assessing Acute Coronary Syndrome

March 3, 2014

Presented by A/Prof Louise Cullen MBBS(Hon) FACEM, Senior Staff Specialist, Department of Emergency Medicine

Playback

Slides

The Value of Point of Care Troponin Testing in Assessing Acute Coronary Syndrome Session 1

Patients with suspected acute coronary syndrome (ACS) make up roughly 10% of Emergency Department (ED) presentations. Approximately 80-90% of these patients are eventually diagnosed with a non-cardiac cause following assessment. Standard clinical diagnostic methods are problematic, with lengthy assessment periods of this cohort contributing to overcrowding and delayed care in the emergency department.

Within the last decade, troponin assays have become available for use at the patients’ bedside in point-of-care (POC) devices. These devices allow shorter real-time results to be available to clinicians in comparison to lab-based assays. However, POC devices have been slow to be adopted in routine clinical care.

This webinar will address the current evidence for POC-based troponin testing, analyze the reliability of existing POC assays, discuss the potential impact on outcomes and safety, illustrate effects on length of stay and patient flow in the ED, and examine the changes needed to maximize the potential benefits of POC troponin testing.

Presenter:
A/Prof Louise Cullen MBBS(Hon) FACEM
Senior Staff Specialist, Department of Emergency Medicine
A/Prof, Queensland University of Technology
Snr Lecturer, University of Queensland, Royal Brisbane and Women’s Hospital
Brisbane, Queensland, AUSTRALIA

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, an account will be created for you automatically.